Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Aequus Pharmaceuticals Inc (AQS.VN)

Aequus Pharmaceuticals Inc (AQS.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aequus Pharmaceuticals Inc 200 Granville Street Suite 2820 Vancouver BC V6C 1S4 CAN

https://www.aequuspharma.ca P: 604-336-7906

Description:

Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The Company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products, namely Tacrolimus IR and Vistitan.

Key Statistics

Overview:

Market Capitalization, $K 1,990
Shares Outstanding, K 132,634
Annual Sales, $ 255 K
Annual Net Income, $ -2,965 K
Last Quarter Sales, $ 53 K
Last Quarter Net Income, $ -662 K
60-Month Beta -0.29
% of Institutional Shareholders 3.92%

Growth:

1-Year Return -50.00%
3-Year Return -86.96%
5-Year Return -91.67%
5-Year Revenue Growth -28.97%

Per-Share Information:

Most Recent Earnings 0.00 on 05/09/24
Next Earnings Date 09/03/24
Earnings Per Share ttm -0.01
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 5.13%
Dividend Payout Ratio 0.00%

AQS.VN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % -263.88%
Profit Margin % -1,163.11%
Debt/Equity N/A
Price/Sales 9.25
Price/Book N/A
Book Value/Share -0.04
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar